Haemophilus Influenzae Serotype b (Hib) Completed Phase 4 Trials for Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)

Also known as: Haemophilus Influenzae Type b (Hib) / Haemophilus Influenzae Type B

IndicationStatusPhase
DBCOND0059781 (Haemophilus Influenzae Serotype b (Hib))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01659996Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgePrevention
NCT00254917Assessment of the Immunogenicity and Safety of PENTAXIM™ in PhilippinesPrevention
NCT00454987Study of Long-term Antibody Persistence After a Booster Dose of Menitorix VaccinePrevention
NCT00753649Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in InfantsPrevention
NCT01457547Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination CoursePrevention
NCT02853929Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryPrevention